Dr. Bryan L. Balmadrid, MD

Dr. Balmadrid practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Balmadrid's NPI, 1548480155, was assigned on April 26, 2007. Dr. Balmadrid graduated from Medical College of Wisconsin in 2004. Dr. Balmadrid holds Washington license MD60272404.

Dr. Balmadrid's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Balmadrid's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Dr. Balmadrid is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Balmadrid to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balmadrid practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Balmadrid's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Balmadrid is licensed in Washington.

CMS data shows 126 Medicare services from Dr. Balmadrid across 6 procedure codes in 2024, for 154 Medicare patients. Medicare paid $16,151 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Dr. Balmadrid in 2024. The largest group is 65 to 74, with 75 patients. 68% of them have high blood pressure, and 61% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balmadrid's median patient age at 55, with 49% women.

In 2024, Dr. Balmadrid wrote 312 Medicare Part D claims for 161 patients. 69% of them were for generic drugs. CMS names the drug for 187 of them, across 6 drugs with 11 or more claims each, at $3,322 in total drug cost. In 2023, CMS named 234 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Balmadrid for performance year 2024, reported through an alternative payment model (APM). Dr. Balmadrid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Balmadrid as offering telehealth. CMS counts 106 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Balmadrid, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Balmadrid, published from 2012 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Gastrointestinal Diseases, Graft vs Host Disease and Hematopoietic Stem Cell Transplantation. Dr. Balmadrid has published most often in Gastrointest Endosc. Dr. Balmadrid's most frequent co-authors are Anthony D. Sung, MD, Daniel M. Wild, MD and Aravind Arepally, MD.

CMS Open Payments shows 27 general payments to Dr. Balmadrid from 9 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 31% of the total. Cook Medical LLC paid the most, $3,088.

Dr. Balmadrid graduated from Medical College of Wisconsin in 2004.